Michael Capaldi is Executive Director for the Institute for Gene Therapies. Prior to this role, Michael completed a 22-year career at Sanofi, a global leader in pharmaceuticals, vaccines and biologics, where he acquired a broad set of experiences across multiple therapeutic areas. His career included roles in public affairs leadership across diabetes, cardiovascular, oncology, cell & organ transplant, joint health and consumer health divisions.
Michael has also shared his time and expertise in a number of other roles benefiting the healthcare community. From 2006 to 2012, he served on the board of the Society of Pharmaceutical & Biotech Trainers, now L-TEN, and acted as President in 2011 and 2012.
Michael has a bachelor’s degree from the Ohio State University and earned a master’s in education for corporate training & knowledge management.